首页> 外国专利> ORAL CONTRACEPTION (LONG-CYCLE REGIMEN AND 21-DAYS-REGIMEN WITH 30 MG ETHINYLESTRADIOL AND 2 MG DIENOGEST) WITHOUT TREATMENT OF THROMBOSIS/HEMOSTASIS

ORAL CONTRACEPTION (LONG-CYCLE REGIMEN AND 21-DAYS-REGIMEN WITH 30 MG ETHINYLESTRADIOL AND 2 MG DIENOGEST) WITHOUT TREATMENT OF THROMBOSIS/HEMOSTASIS

机译:口服避孕药(长周期疗法和21天治疗方案,含30毫克乙炔二醇和2毫克地诺司汀),无需治疗血栓形成/渗血

摘要

The kit for long-cycle administration of a monophasic oral contraceptive preparation without affecting blood pressure advantageously consists of 84 daily dose units, which each contains a combination of 2.0 mg of dienogest and 0.030 mg of ethinyl estradiol, and 7 daily dose units that do not contain any active contraceptive agent or contain a placebo. During long-cycle administration over the course of a year using four 91-day cycle kits, no significant differences in the resulting hemostatic variables in comparison to those obtained during conventional administration with 28-day cycle kits, which each contain 21 daily dose units each containing the combination and 7 daily dose units without the combination or with a placebo, were observed at any time.
机译:用于长期服用单相口服避孕药而不影响血压的试剂盒有利地由84个日剂量单位组成,每个剂量单位包含2.0毫克的地诺孕和0.030毫克的乙炔雌二醇的组合,以及7个不剂量的日剂量单位。包含任何有效的避孕药或安慰剂。在一年中使用四个91天周期试剂盒进行长周期给药的过程中,与常规给药28天周期试剂盒获得的止血变量相比,其止血变量无明显差异,后者分别包含21个日剂量单位在任何时候都可以观察到含有该组合的药物和7个每日剂​​量单位(不含该组合或安慰剂)。

著录项

  • 公开/公告号US2009099144A1

    专利类型

  • 公开/公告日2009-04-16

    原文格式PDF

  • 申请/专利权人 KATRIN MITTMANN;

    申请/专利号US20080248583

  • 发明设计人 KATRIN MITTMANN;

    申请日2008-10-09

  • 分类号A61K31/565;

  • 国家 US

  • 入库时间 2022-08-21 19:35:43

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号